A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
Hypothesis:
- H1: Efficacy of Duotrav will be superior to Xalacom at 24 hours post dosing when both
medications are given in the morning
- H2: A significant proportion of patients will prefer dosing of once daily topical fixed
combination therapy in the morning compared to evening dosing